{
  "disease_name": "Prostate Cancer",
  "synonyms": [
    "Prostate carcinoma"
  ],
  "summary": "Prostate cancer is a type of cancer that forms in the prostate, a gland in the male reproductive system. It is one of the most common cancers in men and often grows slowly, but can sometimes grow quickly and spread to other parts of the body. The disease is characterized by the uncontrolled growth of cells in the prostate.",
  "causes": [
    "Changes in genetic material (DNA)",
    "Inherited genetic changes",
    "Genetic changes that occur during a person's lifetime",
    "Accumulation of genetic mutations to the DNA of cells in the prostate",
    "Mutations affecting genes involved in cell growth, replication, cell death, and DNA damage repair",
    "Gene fusion between TMPRSS2 and the oncogene ERG",
    "Mutations that disable SPOP",
    "Mutations that hyperactivate FOXA1"
  ],
  "risk_factors": [
    "Increasing age",
    "Family history of prostate cancer",
    "African American race",
    "Obesity",
    "High levels of blood cholesterol",
    "Taller height"
  ],
  "symptoms": [
    "Problems urinating (weak stream, difficulty starting, frequent urination, nocturia, pain or burning during urination)",
    "Blood in urine or semen",
    "Pain in lower back, hips, or pelvis",
    "Painful ejaculation",
    "Erectile dysfunction",
    "Unexplained weight loss",
    "Back or bone pain",
    "Leg weakness or paralysis",
    "Fatigue",
    "Lethargy",
    "Generalized weakness",
    "Loss of appetite",
    "Nausea",
    "Constipation",
    "Anemia",
    "Lymphedema (swelling in genitals or lower limbs)",
    "Anxiety",
    "Depression",
    "Confusion",
    "Hallucinations"
  ],
  "diagnosis": [
    "Digital rectal exam (DRE)",
    "Prostate-specific antigen (PSA) blood test",
    "Imaging tests (ultrasound, MRI, CT scan, PSMA scan, bone scintigraphy)",
    "Prostate biopsy",
    "Gleason score",
    "Staging (TNM system, Cambridge Prognostic Group)",
    "Measurement of free PSA",
    "Prostate Health Index",
    "4K score",
    "Kallikrein-2 blood test",
    "PCA3 urine test",
    "TMPRSS2-ERG urine test"
  ],
  "treatments": [
    "Observation",
    "Watchful waiting",
    "Active surveillance",
    "Surgery (radical prostatectomy)",
    "Radiation therapy (intensity-modulated radiation therapy, brachytherapy, external beam radiotherapy)",
    "Hormone therapy (androgen deprivation therapy, GnRH agonists, GnRH antagonists)",
    "Chemotherapy (docetaxel, cabazitaxel, mitoxantrone)",
    "Targeted therapy",
    "Immunotherapy (Sipuleucel-T)",
    "Lu-177 PSMA",
    "Pembrolizumab",
    "PARP inhibitors (olaparib, rucaparib, niraparib)",
    "Steroids",
    "Bone modifying agents (zoledronic acid, denosumab)",
    "Radioactive compounds (radium-223, samarium-153-EDTMP)",
    "Appetite-increasing drugs (megestrol acetate, corticosteroids)",
    "Antiemetics",
    "Blood transfusions",
    "Psychological interventions (psychoeducation, cognitive behavioral therapy)"
  ],
  "related_genes": [
    "BRCA2",
    "HOXB13",
    "BRCA1",
    "ATM",
    "NBS1",
    "MSH2",
    "MSH6",
    "PMS2",
    "CHEK2",
    "RAD51D",
    "PALB2",
    "MYC",
    "Vitamin D receptor",
    "Androgen receptor",
    "CYP3A4",
    "CYP17",
    "TMPRSS2",
    "ERG",
    "SPOP",
    "FOXA1",
    "p53",
    "RB1",
    "PTEN",
    "APC",
    "CTNNB1",
    "PI3KCA",
    "PI3KCB",
    "AKT1"
  ],
  "subtypes": [
    "Castration-resistant prostate cancer (CRPC)",
    "Castration-sensitive prostate cancer"
  ]
}